Epstein–Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma
Open Access
- 30 July 2022
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (7) , 1-14
Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy ubiquitously associated with Epstein–Barr virus (EBV). EBV generates various viral microRNAs (miRNAs) by processing the BHRF1 and BamHI A rightward (BART) transcripts. These BART miRNAs are abundantly expressed in NPC, but their functions and molecular mechanisms remain largely unknown. Our study found that the EBV-encoded microRNA BART-22 was significantly upregulated in NPC tissues and positively correlated with tumor progression. Furthermore, we found that EBV-miR-BART-22 was a significant predictor of poor prognosis in NPC. A reliable nomogram model to predict the preoperative overall survival (OS) of NPC patients was established. The area under the receiver operating characteristic (ROC) curve value for 5-year survival was 0.91. Elevated levels of EBV-miR-BART-22 significantly promoted the epithelial-mesenchymal transition (EMT) and metastasis of NPC cells in vivo and in vitro. We found that EBV-miR-BART-22 directly targets the 3′-UTR of MOSPD2 mRNA to promote the EMT and metastasis of NPC cells by activating the Wnt/β-catenin signaling pathway. Our findings provide a potential prognostic biomarker and new insight into the molecular mechanisms of NPC metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (81702879)
This publication has 63 references indexed in Scilit:
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep SequencingPLOS ONE, 2010
- Sperm and oocyte communication mechanisms controllingC. elegansfertilityDevelopmental Dynamics, 2009
- Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal CarcinomasJournal of Virology, 2009
- Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal CarcinomaJournal of Virology, 2009
- A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interferenceNucleic Acids Research, 2009
- Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinomaJournal of Translational Medicine, 2008
- Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric CarcinomaJournal of Virology, 2007
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964